Michael Lidsky, MD, FACS
@michael_lidsky
Surgical Oncologist and Hepatopancreatobiliary Surgeon @DukeSurgery, Basic and Translational Surgeon-Scientist @DukeUniversity @DukeSurgOnc
ID: 1263888784858333184
22-05-2020 17:45:54
420 Tweet
1,1K Takipçi
628 Takip Edilen
The best part of Twitter (X) has always been 🔥 connections with friends/colleagues from afar 🌎. So happy to get QT w/ my “old school” social media buddy Marissa Boeck MD MPH FACS—reigniting over shared health equity research interests this week Health Disparities Health Disparities Research Institute! 💟
Our surgical oncologists continue to lead as PI’s of multiple clinical trials that expand options for therapy for our most vulnerable patients, including those with unresectable cancers. Michael Lidsky, MD, FACS ECOG-ACRIN Cancer Research Group
Pleased to contribute SURGERY Journal editorial w/ 2⭐️'s, Michela Fabricius (she/her) & Amika Ekanem. Thoughtful planning re: operative approach is 🔑 to limit morbidity & mortality for pts with resectable gallbladder cancer. 🚨: Gen surg PD's-lookout for Amika Ekanem this application cycle!
EA2222 will fill a critical knowledge gap! Enrolling Duke Cancer UAB Surgery CU Surgical Oncology Winship Cancer Institute of Emory University UChicago Surgery Markey Cancer Center Michigan Surgery Corewell Health Mayo Clinic Siteman Cancer Center Memorial Sloan Kettering Cancer Center Mount Sinai Health System Fox Chase Cancer Center UT Southwestern Medical Center + others opening soon!
one of the most important studies out there right now. Kudos to Michael Lidsky, MD, FACS and surgical colleagues for getting this study approved--the definitive answer to a decades old question.
Michael Lidsky, MD, FACS Duke Cancer UAB Surgery CU Surgical Oncology Winship Cancer Institute of Emory University UChicago Surgery Markey Cancer Center Michigan Surgery Corewell Health Mayo Clinic Siteman Cancer Center Memorial Sloan Kettering Cancer Center Mount Sinai Health System Fox Chase Cancer Center UT Southwestern Medical Center Also at Vanderbilt-Ingram Cancer Center ! #cancer #cancerresearch ECOG-ACRIN Cancer Research Group
With the increase in registry use for cancer research, knowing when to use which dataset is paramount to address each research question appropriately. Allison Martin, MD MPH Zhi Ven Fong, MD MPH DrPH et al provide guidance on this topic in their new review: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… OncoAlert
We just had a great talk by Coach Scheyer of Duke Basketball on how to recruit talent! Perfect pump up for the first of our town halls tonight! Sign up here: duke.is/GSUTownHalls20…🏀💙🏀 Duke Basketball Jon Scheyer
Amazing. The future of surgery is bright! Duke Surgery Duke General Surgery Residency
So many similarities and parallels between surgical training and elite sports. Thanks Jon Scheyer for taking time out of your day to chat with us! Duke Surgery Duke General Surgery Residency Ryan Antiel, MD, MSME Duke Men’s Basketball Duke Health Duke University School of Medicine Duke University Kevin N Shah
.Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorectal liver metastases. Learn more: bit.ly/ea2222-pump cc : Colorectal Cancer Alliance, Fight Colorectal Cancer, National Colorectal Cancer Roundtable
So fun to have one of my mentors, colleagues + friends, Peter Kingham visit Durham and give an inspiring Grand Rounds Duke Surgery -incredible to see what he, Prof Alatise, and the entire ARGO Research team have accomplished to advance cancer care in Nigeria. Memorial Sloan Kettering Cancer Center
#ClinicalTrial EA2222/PUMP, led by Michael Lidsky, MD, FACS, is a randomized phase 3 study of #SystemicTherapy with or without hepatic arterial infusion for unresectable #Colorectal liver metastases. More here: bit.ly/ea2222-pump cc: Michael D’Angelica, Shishir K. Maithel, Andrea Cercek